Phospholipids and LPCATs are reported to be key factors in cell growth, tumor progression, and cancer aggressiveness, especially LPCAT1 (28, 29), but only a few studies have investigated the roles of LPCAT2 in regulating phospholipids only in colorectal cancer (CRC) patients (30, 31). The gene discussed is LPCAT2; the disease is colorectal cancer.